Evidence map›Paper›PMID 19228876›Full record

ArticleInternational immunology2009

c-Abl-deficient mice exhibit reduced numbers of peritoneal B-1 cells and defects in BCR-induced B cell activation.

Rachel A Liberatore, Stephen P Goff

Open access · bronzeAbstract read
In one paragraph

Article in International immunology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.5field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. A Role for the Non-Receptor Tyrosine Kinase Abl2/Arg in Experimental Neuroinflammation.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2018
    Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Rachel A LiberatoreColumbia University, New York, NY, USA.
Stephen P Goff
Columbia University · USHoward Hughes Medical Institute · US

Funding

THE DETERMINANTS OF MUTATIONP01CA023767 · NCI · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI AXEL, RICHARD · 1985 to 2008
$8.3M
IMMUNOLOGICAL DISEASE MECHANISMST32AI007525 · NIAID · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI GHOSH, SANKAR · 1997 to 2006
$2.3M
NCI NIH HHS P01 CA 023767NIAID NIH HHS T32 AI 7525
6 · The paper itself

Abstract

A role for c-Abl in B cell development and signaling has been suggested by previous work showing that c-Abl-deficient mice have defects in bone marrow B cell development and that c-Abl-deficient B cells are hypoproliferative in response to antigen receptor stimulation. Here we show that in addition to defects in early B cell development, c-Abl-deficient mice have defects in peripheral B cell development, including reduced percentages of peritoneal B-1 cells as well as transitional and marginal zone B cells in the spleen. It has been shown that c-Abl kinase activity increases upon B cell receptor (BCR) stimulation and that one of the targets of tyrosine phosphorylation by c-Abl is CD19. However, the consequences of c-Abl activity on B cell activation and CD19 signaling remain unknown. Here, we show that c-Abl-deficient splenic B cells exhibit reduced calcium flux in response to CD19 cross-linking, consistent with a role for c-Abl in CD19-dependent signaling. Additionally, we show that c-Abl-deficient B cells are defective in their ability to be activated in response to antigen receptor engagement, suggesting a functional role for c-Abl in BCR-dependent activation signaling pathways.

Indexed as

AnimalsAntigens, CD19B-Lymphocyte SubsetsCalciumCarrier ProteinsLymphocyte ActivationLymphocyte CountMiceMice, Inbred C57BLMice, KnockoutMice, Mutant StrainsNeoplasm ProteinsPeritoneumProto-Oncogene Proteins c-ablProto-Oncogene Proteins c-relReceptors, Antigen, B-CellAntigens, CD19CalciumCarrier ProteinsNeoplasm ProteinsProto-Oncogene Proteins c-ablProto-Oncogene Proteins c-relReceptors, Antigen, B-CellRela protein, mouseTranscription Factor RelA

Identifiers

PMID19228876
PMCPMC2660863
OpenAlexW2143764141

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.